Sign up for free insights newsletter
DH

Diversified Healthcare Trust

DHCUnited States

Need professional-grade analysis? Visit stockanalysis.com

$6.71
-5.89%
End of day
Market Cap

$1.75B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

0.54%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino8.314.486.416.24
Calmar20.269.6310.8812.80
Sharpe4.502.683.263.38
Omega1.671.431.541.54
Martin58.1721.9928.2033.62
Ulcer3.875.236.255.32

Diversified Healthcare Trust (DHC) Price Performance

Diversified Healthcare Trust (DHC) trades on United States in USD. The company is classified in the Real Estate sector under the REIT - Healthcare Facilities industry. The stock currently trades at $6.71, down 5.89% from the previous close.

Over the past year, DHC has traded between a low of $2.05 and a high of $7.55. The stock has gained 180.5% over this period. It is currently 11.1% below its 52-week high.

Diversified Healthcare Trust has a market capitalization of $1.75B and a dividend yield of 0.54%.

About Diversified Healthcare Trust

DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of September 30, 2025, DHC's approximately $6.7 billion portfolio included 335 properties in 34 states and Washington, D.C., with more than 26,000 senior living units, approximately 6.9 million square feet of medical office and life science properties and occupied by approximately 420 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with approximately $39 billion in assets under management as of September 30, 2025 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$1.41B
EBITDA
$222.77M
Profit Margin
-18.59%
EPS (TTM)
-1.22
Book Value
6.88

Technical Indicators

52 Week High
$7.60
52 Week Low
$1.98
50 Day MA
$6.18
200 Day MA
$4.59
Beta
2.39

Valuation

Trailing P/E
N/A
Forward P/E
16.64
Price/Sales
1.14
Price/Book
1.05
Enterprise Value
$4.61B